Nearly a dozen Connecticut students hospitalized after taking MDMA – Al Jazeera America

Posted: Monday, February 23, 2015

Eleven students at Wesleyan University in Connecticut have been hospitalized after taking the drug MDMA, also known as molly or ecstasy.

One of the students, a sophomore, is in critical condition, officials said on Sunday. The sophomore at the elite school in Middletown was transported to a hospital early on Sunday with two students in less serious conditions but showing similar symptoms, Michael Whaley, vice president for student affairs, said in an emailed statement to the student body.

Wesleyan spokeswoman Lauren Rubenstein said in an email that seven students were transported to hospitals “with overdose symptoms consistent with the use of Molly (MDMA).” Another four went directly to hospitals, she said. The incident is under investigation, Whaley said.

MDMA, a banned psychoactive substance, rarely causes overdose deaths in itself, according to the harm reduction group DanceSafe. The organization says on its website that calling most MDMA-related deaths overdoses “sends the message that ‘you will be okay as long as you don’t take too much,’ which is simply not true.”

MDMA-involved deaths are more often the result of adulterated pills, heat stroke or mixing drugs, according to Roll Safe, another harm reduction group. 

Molly is the street name for a drug that is pushed as the pure powder form of MDMA. Although molly is widely assumed to be a pure form of MDMA, it and ecstasy often contain added stimulants such as amphetamines, said Roll Safe.

In September, a number of Wesleyan students were hospitalized after taking MDMA, according to an all-campus email sent by university health officials on Sept. 16, the campus newspaper, the Wesleyan Argus, reported.

The same month, authorities blamed a bad batch of ecstasy for the deaths of four people and the hospitalizations of many more in cities including Boston, New York and Washington, D.C.

Al Jazeera and wire services


Write a Reply or Comment:

Your email address will not be published.*